Study Summary
This trial will test whether Matrion can help heal diabetic foot ulcers. Matrion is made from placental tissue and is safe for surgical use.
- Diabetic Foot
- Lower Extremity Wound
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 6 Secondary · Reporting Duration: 6 months post termination visit
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Conventional Care Wound Management
1 of 2
Matrion decellularized placental membrane
1 of 2
Active Control
Experimental Treatment
120 Total Participants · 2 Treatment Groups
Primary Treatment: Matrion · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 21 - 80 · All Participants · 12 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
What is the highest number of participants allowed in this clinical trial?
"In order to conduct this trial, the sponsor, LifeNet Health needs 120 eligible participants. Several sites are hosting this research project including Albuquerque Associated Podiatrists in New Mexico and Compass Medical Research Center LLC in Arizona." - Anonymous Online Contributor
Are candidates aged under 75 years old eligible for admission into this experiment?
"Eligibility for this clinical trial is limited to individuals between 21 and 80 years of age." - Anonymous Online Contributor
Is this research endeavor taking on additional participants?
"A quick glance at clinicaltrials.gov reveals that this medical trial is seeking participants, having first been posted on March 1st of 2022 and most recently amended on April 14th." - Anonymous Online Contributor
To what group of individuals is enrollment in this medical experiment open?
"This clinical trial is currently enrolling 120 individuals aged 21 to 80 with diabetic foot. Qualified participants must meet the following criteria: adhere to Infectious Disease Society of America standards for infection-free, identify as male or female, have a diagnosis of Type I or II diabetes according to American Diabetes Association guidelines and be on steady anti-diabetic drugs for at least one month before baseline visit; possess a single target ulcer larger than 1 cm2 but not exceeding 25cm2 in said wound depth being no more than 9mm; grade 1 superficial diabetic ulcers including full skin tissue without underlying harm; transcutaneous oxygen measurement of 30" - Anonymous Online Contributor
Are there multiple sites conducting this experiment throughout the state?
"Presently, the study is seeking participants from a total of 6 different sites. The available locations are Albuquerque, Tucson and San Diego as well 3 other cities. It's important to pick the closest option in order to reduce unnecessary travel needs when taking part." - Anonymous Online Contributor